Lacropos (Lacropos)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceCarbomerCarbomer
Similar drugsTo uncover
  • Vidisik®
    gel d / eye 
    VALEANT, LLC     Russia
  • Lacropos
    gel d / eye 
    Ursafarm Artsnaymittel GmbH     Germany
  • Ottagel®
    gel d / eye 
    Santen, AO     Finland
    • Dosage form: & nbspeye gel
    Composition:

    1 g of gel contains:

    active substance: Carbomer 980 2.00 mg;

    Excipients: sorbitol 40.00 mg, cetrimide 0.10 mg, sodium hydroxide 0.83 mg, disodium edetate 0.0375 mg, water for injection 957.033 mg.

    Description:

    Colorless or light yellow color gel.

    Pharmacotherapeutic group:Keratoprotective agent
    ATX: & nbsp

    S.01.X.A.20   Artificial tears and other indifferent drugs

    Pharmacodynamics:

    Lacrosse as the main component contains carbomer, which is a high molecular weight polymer and is a combination of polyacrylic acid and water as a dispersion medium.

    The carbomer facilitates the replacement of the aqueous and mucin layers of the tear film, increases the viscosity of the tear, forming a protective moisturizing film on the surface of the cornea.

    Pharmacokinetics:

    Due to its physico-chemical properties, Lakropos gel remains on the surface of the eye for a long time and does not penetrate the tissues of the eye. Carbomer It is not resorbed and deposited in tissues due to the high molecular weight of the carbomer molecule.

    Indications:

    Lacrosse Gel is used as a liquid tear replacement for impaired tear fluid and dry eye syndrome.

    Contraindications:

    - Hypersensitivity to the components of the drug;

    - wearing soft contact lenses;

    - children's age till 18 years.

    Pregnancy and lactation:

    Adequate trials of the drug with the participation of pregnant women were not conducted.

    At pregnancy and during a lactemia application of a preparation only after careful evaluation by the doctor of the benefit / risk relationship from the therapy.

    Dosing and Administration:

    One drop of gel in the conjunctival sac 3-5 times a day, about 30 minutes before bedtime. The frequency of instillation of the gel is determined individually, depending on the severity of the clinical picture and according to the recommendations of the doctor.

    If necessary, Lakropos can be digested more often.

    It is recommended to distribute gel applications evenly throughout the day.

    In cases requiring long-term therapy, you should consult ophthalmologist.

    Mode of application

    Tilt your head slightly back, slightly lift your lower eyelid finger with your index finger.Hold the other tube in an upright position above the eye level (without touching the eye surface) and drip one drop of gel into the conjunctival sac.

    After instillation, slowly move your eyes in different directions for better distribution of the gel. Then gently close your eyes.

    When instilled, avoid contact between the tip of the tube and the surface of the eye and eyelid. After the procedure is finished, put a protective cap on the tube.

    Remove the eye gel from the tube with a gentle pressure, without crushing or twisting the tube.

    Side effects:

    In rare cases, hypersensitivity reactions may occur to one of the components in the preparation, allergic reactions, transient impairment view.

    Lacropos gel contains cetrimide as a preservative, which can cause irritation of the eyes (for example, burning, redness, foreign body feeling), as well as damage to the corneal epithelium, mainly during prolonged therapy.

    Overdose:No cases of overdose were reported.
    Interaction:Interaction with other drugs has not been studied.
    Special instructions:Lakropos gel can prolong the action of other ophthalmic drugs with simultaneous application.

    With the simultaneous use of several eye medicines Lakropos Gel should be instilled last, not earlier than 15 minutes after use eye drops.

    Lacropos gel should not be used when wearing soft contact lenses. Before instillation of the drug, hard contact lenses should be removed and reinstalled 15-30 minutes after instillation of the drug.

    Effect on the ability to drive transp. cf. and fur:Immediately after instillation of the eye gel, Lacropos may experience a brief disturbance of visual acuity, leading to a slowing of mental and physical reactions. Therefore, it is not recommended to apply the drug directly before working with mechanisms and driving vehicles. Within 30 minutes after instillation, it is necessary to refrain from occupations that require increased attention.
    Form release / dosage:

    Eye gel 0.2%.

    Packaging:

    For 10 grams in tubes of aluminum, with a polyethylene tip and a screw cap.

    For 1 or 3 tubes together with the instructions for use are placed in a cardboard box.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C. Do not freeze.

    Keep out of the reach of children.
    Shelf life:

    In closed original packaging: 3 years.

    Use within 4 weeks after opening the tube.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-000470
    Date of registration:01.03.2011
    Expiration Date:01.03.2016
    The owner of the registration certificate:Ursafarm Artsnaymittel GmbHUrsafarm Artsnaymittel GmbH Germany
    Manufacturer: & nbsp
    Representation: & nbspURSAFARM ARTSNAYMITTEL GmbH URSAFARM ARTSNAYMITTEL GmbH Germany
    Information update date: & nbsp10.02.2018
    Illustrated instructions
      Instructions
      Up